1
2
3
4
5
6
2
3
4
5
6
Published In
Archives of Rheumatology
Volume: 35 Issue: 3, September 2020
Pages: 366-375
History
Published Online: September 30, 2020
This work is licensed under a Creative Commons Attribution 4.0 International License.
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Abstract
Objectives: This study aims to assess the efficacy and safety of mycophenolate mofetil (MMF) on lung function and skin thickness in Korean patients with systemic sclerosis-interstitial lung disease (SSc-ILD) in a real-world setting.
Patients and methods: This retrospective, medical chart-based study was performed at four centers in South Korea and included 34 patients (2 males, 32 females; median age 50.5 years; range, 25 to 72 years) with SSc-ILD. We investigated changes in forced vital capacity (FVC), diffusion capacity of the lung for carbon monoxide (DLCO), and modified Rodnan skin score (mRSS) according to MMF treatment for 24 months.
Results: The mean dose and treatment duration of MMF were 1,338.2±439.0 mg/day and 13.1±9.3 months, respectively. Although FVC decreased significantly at 15 months, FVC and DLCO did not change significantly during treatment with MMF. Median mRSS decreased significantly from 17.5 (2-40) to 10.5 (2-40) units (p<0.0001). Thirteen patients (38.24%) discontinued treatment with MMF [treatment duration 8.00 (3.0-24.0) months]; the predominant cause of discontinuation was of economic nature (46.15%). No serious adverse events were reported.
Conclusion: This real-world based study supports the role of MMF in the stabilization of lung function and the improvement in skin thickness with an acceptable safety profile in patients with SSc. Economic burden is the main cause of discontinued treatment with MMF.
Similar Articles
Similar Articles
- Xinzhu Yuan, Changwei Lin, Yanni Zhang, Hongni He, Lingqin Li, miR-23a-5p Alleviates Gouty Inflammation by Targeting Interleukin-17A and Inhibiting NLR Family Pyrin Domain Containing 3 Inflammasome Activation , Archives of Rheumatology: Vol. 40 No. 4 (2025): Archives of Rheumatology
- Ebru ÇAKIR EDİS, Osman N. HATİPOĞLU, Ömer N. PAMUK, Renginar MUTLUCAN ERASLAN, Meryem AKTÖZ, Sedat Alpaslan TUNCEL, Effectiveness of Thoracic Ultrasonography in the Evaluation of the Severity of Pulmonary Involvement in Patients With Systemic Sclerosis , Archives of Rheumatology: Vol. 31 No. 4 (2016): The Archives of Rheumatology
- Qian JIN, Jisheng ZHENG, Xianrong XU, Yeming HU, Ying ZHOU, Weihua XU, Feihua HUANG, Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease , Archives of Rheumatology: Vol. 33 No. 2 (2018): The Archives of Rheumatology
- Ji-su MO, Soo-cheon CHAE, Bone Morphogenetic Protein 6 Polymorphisms are Associated With Systemic Lupus Erythematosus Susceptibility in the Korean Population , Archives of Rheumatology: Vol. 33 No. 4 (2018): The Archives of Rheumatology
- Agata SEBASTIAN, Aleksandra BUTRYM, Maria MISTERSKA SKÓRA, Arkadiusz CHLEBICKI, Grzegorz MAZUR, Piotr WILAND, Systemic Lupus Erythematosus Induced by Autoimmune/ Inflammatory Syndrome Induced by Adjuvants. Is it Possible? Long-Term Follow-up and Literature Review , Archives of Rheumatology: Vol. 33 No. 2 (2018): The Archives of Rheumatology
- Veli SUNAR, Öztürk ATEŞ, Alma KORCALI ASLAN, Yusuf KARAKAŞ, Mustafa Kadri ALTUNDAĞ, The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival , Archives of Rheumatology: Vol. 34 No. 2 (2019): The Archives of Rheumatology
- Ayşe Koçak, Aydan Köken Avşar, Duygu Harmancı, Gül Akdoğan, A. Merih Birlik, A preliminary study of possible fibrotic role of meprin metalloproteases in scleroderma patients , Archives of Rheumatology: Vol. 36 No. 4 (2021): The Archives of Rheumatology
- Songül Çildağ, Gökhan Sargın, Taşkın Şentürk, Clinical and laboratory characteristics of chronic spontaneous urticaria with connective tissue diseases: A cross-sectional study , Archives of Rheumatology: Vol. 37 No. 2 (2022): The Archives of Rheumatology
- Oznur Kutluk, Nimet Ezgi Dabak, Ayca Ayse Yucel, Ahmet Sukru Alparslan, Fatih Cay, The Association Between Obesity Indices and Non-Alcoholic Fatty Liver Disease in Patients with Ankylosing Spondylitis , Archives of Rheumatology: Vol. 40 No. 4 (2025): Archives of Rheumatology
- Ki-Jo KIM, Chul-Soo CHO, Anemia of Chronic Disease in Ankylosing Spondylitis: Improvement Following Anti-TNF Therapy , Archives of Rheumatology: Vol. 27 No. 2 (2012): The Archives of Rheumatology
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Vol. 35 No. 3 (2020): The Archives of Rheumatology
Pages
366-375
History
Published Online
September 30, 2020
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Kyung-Ann LEE
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
2
Bo Young KIM
Department of Internal Medicine, Gangneung Asan Hospital, Gangneung, South Korea
3
Sung Jae CHOI
Department of Internal Medicine, Korea University, Ansan, South Korea
4
Seong-Kyu KIM
Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea
5
Sang-Hyon KIM
Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea
6
Hyun-Sook KIM
Department of Internal Medicine, Soonchunhyang University School of Medicine, Seoul, South Korea
Cite this Article
Kyung-Ann LEE, Bo Young KIM, Sung Jae CHOI, Seong-Kyu KIM, Sang-Hyon KIM, & Hyun-Sook KIM. (2020). A Real-World Experience of Mycophenolate Mofetil for Systemic Sclerosis: A Retrospective Multicenter Observational Study. Archives of Rheumatology, 35(3), 366–375. https://doi.org/10.46497/ArchRheumatol.2020.7771
Outlines